Solutions by stage
Development Submission & Authorization Post-marketing
Specialized fields
Biotech
Pharmacovigilance Overview
Clinical Safety Overview
Quality Management Overview
QPPV
Safety Data Management
Signal & Benefit-Risk
Medical Writing
Pharmacovigilance IT Systems
Clinical Safety
Local Pharmacovigilance
Regulatory Intelligence
Solutions by stage
Development Submission & Authorization Post-marketing
Specialized fields
Biotech
Regulatory Affairs Overview
Regulatory Consulting
Regulatory Applications & Submissions
Regulatory Operations
Solutions by stage
Development Submission & Authorization Post-marketing
Specialized fields
Biotech
Quality Assurance and Auditing Overview
GVP Auditing
Regulatory Inspections
QA Management
QA Consulting
SDEA & PVA Management
Solutions by stage
Development Submission & Authorization Post-marketing
Specialized fields
Biotech
Main menu
QPPV
Safety Data Management
Signal & Benefit-Risk
Medical Writing
Pharmacovigilance IT Systems
Clinical Safety
Local Pharmacovigilance
Regulatory Intelligence
Pharmacovigilance Overview Clinical Safety Overview Quality Management Overview
Main menu
Regulatory Consulting
Regulatory Applications & Submissions
Regulatory Operations
Regulatory Affairs Overview
Main menu
GVP Auditing
Regulatory Inspections
QA Management
QA Consulting
SDEA & PVA Management
Quality Assurance and Auditing Overview
Press Contributors /
Dr. John Price
Regulatory and Safety Consultant and Advisor to Arriello.

Dr. John Price is an executive physician with deep experience gained from over 25 years working across the breadth of regulatory affairs and pharmacovigilance worldwide.

He has created and led high-functioning global departments for pharmacovigilance, regulatory and clinical operations, medical writing and drug development, and held senior roles in the UK Medicines Control Agency (now MHRA), Pfizer, J&J, Alexion Pharmaceuticals, and academia.

25 years global Regulatory and Pharmacovigilance experience.

Press articles by John.

Pharmacovigilance
Quality Overtakes Cost as the Priority as Life Sciences Companies Move to Automate Pharmacovigilance Case Intake.
Pharmacovigilance
PV automation survey finds quality overtaking cost as top priority.
Automation
Automating PV Data Capture: What's stopping Companies?
Automation
Why aren’t more companies automating PV data capture?
Automation
Automating PV data capture.
Automation
Speeding up PV processes with automation.
1 2